• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Genetics

ALS/MND can affect families in different ways. In about 90% of cases, there is only one person in a family with ALS/MND. This is called sporadic ALS/MND. In about 10% of cases, more than one person in the same family is affected. This is known as hereditary or familial ALS/MND and may be linked to a change in a gene that runs in a family.

For some families, understanding hereditary ALS/MND may be an important next step. It can help explain why the condition affects more than one person in the same family and why symptoms may differ across family members. It may also help families understand what information they may want to explore next.

Even in cases of sporadic ALS/MND, meaning there is no known family history, genetics may still be relevant. This is because a genetic change may still be present even when ALS/MND appears to affect only one person in a family. This is one reason information about genetics may be useful to a wider group of people and families.

The materials below support different needs and different levels of interest. They include brief explanations, visual resources, and additional information for those who want to learn more about genetics in ALS/MND.

Starting with the basics

To better understand genetics, it can be helpful to start with the basics. The visual explainers below introduce the genome, DNA, genes, and chromosomes, and provide a simple foundation for the rest of this section.

PDF

What is your genome?

This infographic introduces the genome and shows how DNA, genes, chromosomes, RNA, and proteins are connected. It explains how genetic information is stored and used, helping build a foundation for genetics in ALS/MND.

PDF

Introduction to Genetics

This infographic introduces genetics and how genetic changes can be passed through families in different ways. It helps explain why some are affected, others are unaffected carriers, and why hereditary conditions look different in each family.

Understanding genetics in ALS/MND

The visual explainers below build on these basic concepts and focus more directly on how genetics may relate to ALS/MND and why it may matter for individuals and families.

PDF

Why is genetics relevant to ALS/MND?

This infographic shows how family history and genetic causes do not always fit simple categories. It explains the difference between hereditary and sporadic ALS/MND, varied inheritance patterns, and that a genetic cause can be found even without clear family history.

PDF

Can genes affect the type of ALS/MND?

This infographic explains penetrance, which means that carrying a genetic change does not always mean a person will develop ALS/MND. It also shows that genes can lead to different types of ALS/MND across individuals.

Learn more about genetics in ALS/MND

These resources provide broader introductions to genetics and inherited ALS/MND. They may be helpful for readers who want to build on the visual explainers and explore these topics in more detail.

Video

Introduction to ALS/MND Genetics

This Alliance webinar gives an overview of genetics in ALS/MND and the current ALS/MND landscape. It is intended to help people living with ALS/MND and their families build a basic understanding of genetics, what it may mean for them, and what options may be available.

Webpage

Inherited MND: Introduction

This resource from the MND Association introduces inherited ALS/MND and is useful for readers wanting more after the visual explainers.

Webpage

ALS Genes and Mutations

This resource from the ALS Association explains the genes linked to ALS/MND, including the four most common, and provides an overview of genetic testing.

Primary Sidebar

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Steve

    Steve

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Ali Var, Turkey

    Ali Var, Turkey

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Timmy, Belgium

    Timmy, Belgium

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Mark Miller, UK

    Mark Miller, UK

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Lee Millard, England

    Lee Millard, England

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Greg Heydet, USA

    Greg Heydet, USA

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Jon Newsome, USA

    Jon Newsome, USA

  • Philip Brindle, England

    Philip Brindle, England

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Hollister

    Hollister
    hollister

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Ian Gale, Australia

    Ian Gale, Australia

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Sally Pauls, USA

    Sally Pauls, USA

  • Jack Buzby, USA

    Jack Buzby, USA

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Rob Tison, USA

    Rob Tison, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login